CARDIFF ONCOLOGY INC's ticker is CRDF and the CUSIP is 14147L108. A total of 93 filers reported holding CARDIFF ONCOLOGY INC in Q2 2021. The put-call ratio across all filers is 1.64 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $21 | +50.0% | 15,551 | +48.1% | 0.00% | – |
| Q4 2022 | $14 | -100.0% | 10,500 | -52.5% | 0.00% | – |
| Q3 2022 | $34,000 | -76.7% | 22,105 | -66.8% | 0.00% | – |
| Q2 2022 | $146,000 | +124.6% | 66,545 | +151.0% | 0.00% | – |
| Q1 2022 | $65,000 | -82.0% | 26,507 | -55.9% | 0.00% | – |
| Q4 2021 | $361,000 | +1144.8% | 60,136 | +1248.3% | 0.00% | – |
| Q3 2021 | $29,000 | -6.5% | 4,460 | -7.2% | 0.00% | – |
| Q2 2021 | $31,000 | +342.9% | 4,806 | +1089.6% | 0.00% | – |
| Q4 2020 | $7,000 | – | 404 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACT CAPITAL MANAGEMENT, LLC | 120,600 | $299,000 | 0.32% |
| Artal Group S.A. | 750,000 | $1,860,000 | 0.08% |
| Eventide Asset Management | 1,467,922 | $3,640,000 | 0.06% |
| Atom Investors LP | 33,798 | $84,000 | 0.04% |
| XTX Topco Ltd | 25,154 | $62,000 | 0.03% |
| ELKHORN PARTNERS LIMITED PARTNERSHIP | 19,000 | $47,000 | 0.02% |
| Engineers Gate Manager LP | 245,567 | $609,000 | 0.02% |
| GSA CAPITAL PARTNERS LLP | 63,749 | $158,000 | 0.02% |
| KENNEDY CAPITAL MANAGEMENT LLC | 168,902 | $419,000 | 0.01% |
| Walleye Capital LLC | 123,305 | $306,000 | 0.01% |